These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Tinkering with heparan sulfate sulfation to steer development. Gorsi B; Stringer SE Trends Cell Biol; 2007 Apr; 17(4):173-7. PubMed ID: 17320398 [TBL] [Abstract][Full Text] [Related]
28. Human extracellular sulfatases use a dual mechanism for regulation of growth factor interactions with heparan sulfate proteoglycans. Timm BM; Follmar JL; Porell RN; Glass K; Thacker BE; Glass CA; Godula K bioRxiv; 2023 Nov; ():. PubMed ID: 38045270 [TBL] [Abstract][Full Text] [Related]
29. Tumour-necrosis factor-α induces heparan sulfate 6-O-endosulfatase 1 (Sulf-1) expression in fibroblasts. Sikora AS; Hellec C; Carpentier M; Martinez P; Delos M; Denys A; Allain F Int J Biochem Cell Biol; 2016 Nov; 80():57-65. PubMed ID: 27693418 [TBL] [Abstract][Full Text] [Related]
30. Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells. Nawroth R; van Zante A; Cervantes S; McManus M; Hebrok M; Rosen SD PLoS One; 2007 Apr; 2(4):e392. PubMed ID: 17460759 [TBL] [Abstract][Full Text] [Related]
32. Kinetic analysis of amyloid formation in the presence of heparan sulfate: faster unfolding and change of pathway. Motamedi-Shad N; Monsellier E; Torrassa S; Relini A; Chiti F J Biol Chem; 2009 Oct; 284(43):29921-34. PubMed ID: 19700762 [TBL] [Abstract][Full Text] [Related]
33. Trisaccharide Sulfate and Its Sulfonamide as an Effective Substrate and Inhibitor of Human Endo- Chiu LT; Sabbavarapu NM; Lin WC; Fan CY; Wu CC; Cheng TR; Wong CH; Hung SC J Am Chem Soc; 2020 Mar; 142(11):5282-5292. PubMed ID: 32083852 [TBL] [Abstract][Full Text] [Related]
34. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases. Li JP; Zhang X Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729 [TBL] [Abstract][Full Text] [Related]
35. Heparan sulfate-protein interactions--a concept for drug design? Lindahl U Thromb Haemost; 2007 Jul; 98(1):109-15. PubMed ID: 17598000 [TBL] [Abstract][Full Text] [Related]
36. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis. Lemjabbar-Alaoui H; van Zante A; Singer MS; Xue Q; Wang YQ; Tsay D; He B; Jablons DM; Rosen SD Oncogene; 2010 Feb; 29(5):635-46. PubMed ID: 19855436 [TBL] [Abstract][Full Text] [Related]
37. Expression and purification of recombinant extracellular sulfatase HSulf-2 allows deciphering of enzyme sub-domain coordinated role for the binding and 6-O-desulfation of heparan sulfate. Seffouh A; El Masri R; Makshakova O; Gout E; Hassoun ZEO; Andrieu JP; Lortat-Jacob H; Vivès RR Cell Mol Life Sci; 2019 May; 76(9):1807-1819. PubMed ID: 30788513 [TBL] [Abstract][Full Text] [Related]
38. Extracellular endosulfatase Sulf-2 harbors a chondroitin/dermatan sulfate chain that modulates its enzyme activity. El Masri R; Seffouh A; Roelants C; Seffouh I; Gout E; Pérard J; Dalonneau F; Nishitsuji K; Noborn F; Nikpour M; Larson G; Crétinon Y; Friedel-Arboleas M; Uchimura K; Daniel R; Lortat-Jacob H; Filhol O; Vivès RR Cell Rep; 2022 Mar; 38(11):110516. PubMed ID: 35294879 [TBL] [Abstract][Full Text] [Related]
39. Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches. Huang Y; Mao Y; Buczek-Thomas JA; Nugent MA; Zaia J PLoS One; 2014; 9(8):e105143. PubMed ID: 25127119 [TBL] [Abstract][Full Text] [Related]